Merck & Co »

Xilio Therapeutics shares owned by Merck & Co

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Merck & Co from 13F filings

Historical chart of Merck & Co investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Merck & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Merck & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 1.5M 0.84
2025-06-30 $1.0M 1.5M 0.68